BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15563506)

  • 1. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.
    Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR
    Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collagen VI-related muscle disorders].
    Higuchi I
    Brain Nerve; 2011 Nov; 63(11):1169-78. PubMed ID: 22068469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular consequences of dominant Bethlem myopathy collagen VI mutations.
    Baker NL; Mörgelin M; Pace RA; Peat RA; Adams NE; Gardner RJ; Rowland LP; Miller G; De Jonghe P; Ceulemans B; Hannibal MC; Edwards M; Thompson EM; Jacobson R; Quinlivan RC; Aftimos S; Kornberg AJ; North KN; Bateman JF; Lamandé SR
    Ann Neurol; 2007 Oct; 62(4):390-405. PubMed ID: 17886299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families.
    Peat RA; Baker NL; Jones KJ; North KN; Lamandé SR
    Neuromuscul Disord; 2007 Jul; 17(7):547-57. PubMed ID: 17537636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci.
    Demir E; Ferreiro A; Sabatelli P; Allamand V; Makri S; Echenne B; Maraldi M; Merlini L; Topaloglu H; Guicheney P
    Neuropediatrics; 2004 Apr; 35(2):103-12. PubMed ID: 15127309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan.
    Okada M; Kawahara G; Noguchi S; Sugie K; Murayama K; Nonaka I; Hayashi YK; Nishino I
    Neurology; 2007 Sep; 69(10):1035-42. PubMed ID: 17785673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Collagenopathy (Ullrich congenital muscular dystrophy, Bethlem myopathy)].
    Higuchi I
    Rinsho Shinkeigaku; 2005 Nov; 45(11):935-7. PubMed ID: 16447767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy.
    Pepe G; Lucarini L; Zhang RZ; Pan TC; Giusti B; Quijano-Roy S; Gartioux C; Bushby KM; Guicheney P; Chu ML
    Ann Neurol; 2006 Jan; 59(1):190-5. PubMed ID: 16278855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance.
    Lampe AK; Zou Y; Sudano D; O'Brien KK; Hicks D; Laval SH; Charlton R; Jimenez-Mallebrera C; Zhang RZ; Finkel RS; Tennekoon G; Schreiber G; van der Knaap MS; Marks H; Straub V; Flanigan KM; Chu ML; Muntoni F; Bushby KM; Bönnemann CG
    Hum Mutat; 2008 Jun; 29(6):809-22. PubMed ID: 18366090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.
    Pan TC; Zhang RZ; Sudano DG; Marie SK; Bönnemann CG; Chu ML
    Am J Hum Genet; 2003 Aug; 73(2):355-69. PubMed ID: 12840783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease.
    Kawahara G; Okada M; Morone N; Ibarra CA; Nonaka I; Noguchi S; Hayashi YK; Nishino I
    Neurology; 2007 Sep; 69(10):1043-9. PubMed ID: 17785674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations.
    Jimenez-Mallebrera C; Maioli MA; Kim J; Brown SC; Feng L; Lampe AK; Bushby K; Hicks D; Flanigan KM; Bonnemann C; Sewry CA; Muntoni F
    Neuromuscul Disord; 2006 Oct; 16(9-10):571-82. PubMed ID: 16935502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy.
    Lucioli S; Giusti B; Mercuri E; Vanegas OC; Lucarini L; Pietroni V; Urtizberea A; Ben Yaou R; de Visser M; van der Kooi AJ; Bönnemann C; Iannaccone ST; Merlini L; Bushby K; Muntoni F; Bertini E; Chu ML; Pepe G
    Neurology; 2005 Jun; 64(11):1931-7. PubMed ID: 15955946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant mitochondria in a Bethlem myopathy patient with a homozygous amino acid substitution that destabilizes the collagen VI α2(VI) chain.
    Zamurs LK; Idoate MA; Hanssen E; Gomez-Ibañez A; Pastor P; Lamandé SR
    J Biol Chem; 2015 Feb; 290(7):4272-81. PubMed ID: 25533456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant.
    Zhang RZ; Zou Y; Pan TC; Markova D; Fertala A; Hu Y; Squarzoni S; Reed UC; Marie SKN; Bönnemann CG; Chu ML
    J Biol Chem; 2010 Mar; 285(13):10005-10015. PubMed ID: 20106987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy.
    Demir E; Sabatelli P; Allamand V; Ferreiro A; Moghadaszadeh B; Makrelouf M; Topaloglu H; Echenne B; Merlini L; Guicheney P
    Am J Hum Genet; 2002 Jun; 70(6):1446-58. PubMed ID: 11992252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy.
    Lampe AK; Dunn DM; von Niederhausern AC; Hamil C; Aoyagi A; Laval SH; Marie SK; Chu ML; Swoboda K; Muntoni F; Bonnemann CG; Flanigan KM; Bushby KM; Weiss RB
    J Med Genet; 2005 Feb; 42(2):108-20. PubMed ID: 15689448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of Ullrich congenital muscular dystrophy using haplotype analysis and collagen VI immunocytochemistry.
    Brockington M; Brown SC; Lampe A; Yuva Y; Feng L; Jimenez-Mallebrera C; Sewry CA; Flanigan KM; Bushby K; Muntoni F
    Prenat Diagn; 2004 Jun; 24(6):440-4. PubMed ID: 15229843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy.
    Lucarini L; Giusti B; Zhang RZ; Pan TC; Jimenez-Mallebrera C; Mercuri E; Muntoni F; Pepe G; Chu ML
    Hum Genet; 2005 Sep; 117(5):460-6. PubMed ID: 16075202
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.